Pre-clinical toxicology of AAV2/5-OPTIRPE65, an optimised RPE65 gene therapy vector

被引：0
|
作者：
Georgiadis, A. [1 ,3 ]
Duran, Y. [1 ]
Ribeiro, J. [1 ]
Abelleira, L. [1 ]
Naylor, S. [3 ]
Smith, A. J. [1 ,3 ]
Bainbridge, J. W. B. [1 ,2 ,3 ]
Ali, R. R. [1 ,2 ,3 ]
机构：
[1] UCL Inst Ophthalmol, London, England
[2] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[3] MeiraGTx Ltd, London, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P220
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 34 条
  • [1] Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
    Georgiadis, A.
    Duran, Y.
    Ribeiro, J.
    Abelleira-Hervas, L.
    Robbie, S. J.
    Sunkel-Laing, B.
    Fourali, S.
    Gonzalez-Cordero, A.
    Cristante, E.
    Michaelides, M.
    Bainbridge, J. W. B.
    Smith, A. J.
    Ali, R. R.
    GENE THERAPY, 2016, 23 (12) : 857 - 862
  • [2] Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
    A Georgiadis
    Y Duran
    J Ribeiro
    L Abelleira-Hervas
    S J Robbie
    B Sünkel-Laing
    S Fourali
    A Gonzalez-Cordero
    E Cristante
    M Michaelides
    J W B Bainbridge
    A J Smith
    R R Ali
    Gene Therapy, 2016, 23 : 857 - 862
  • [3] Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
    A. Georgiadis
    Y. Duran
    J. Ribeiro
    L. Abelleira-Hervas
    S. J. Robbie
    B. Sünkel-Laing
    S. Fourali
    A. Gonzalez-Cordero
    E. Cristante
    M. Michaelides
    J. W. B. Bainbridge
    A. J. Smith
    R. R. Ali
    Gene Therapy, 2018, 25 : 450 - 450
  • [4] Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65 (vol 23, pg 857, 2016)
    Georgiadis, A.
    Duran, Y.
    Ribeiro, J.
    Abelleira-Hervas, L.
    Robbie, S. J.
    Sunkel-Laing, B.
    Fourali, S.
    Gonzalez-Cordero, A.
    Cristante, E.
    Michaelides, M.
    Bainbridge, J. W. B.
    Smith, A. J.
    Ali, R. R.
    GENE THERAPY, 2018, 25 (06) : 450 - 450
  • [5] Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65 (vol 23, pg 857, 2016)
    Georgiadis, A.
    Duran, Y.
    Ribeiro, J.
    Abelleira-Hervas, L.
    Robbie, S. J.
    Sunkel-Laing, B.
    Fourali, S.
    Gonzalez-Cordero, A.
    Cristante, E.
    Michaelides, M.
    Bainbridge, J. W. B.
    Smith, A. J.
    Ali, R. R.
    GENE THERAPY, 2024, 31 (9-10) : 524 - 524
  • [6] Improved Retinal Function After AAV Gene Therapy: An Update on the RPE65 Clinical Trial
    Smith, A. J.
    Bainbridge, J. W. B.
    Robbie, S.
    Barker, S. E.
    Rubin, G. S.
    Moore, A. T.
    Ali, R. R.
    HUMAN GENE THERAPY, 2010, 21 (04) : 504 - 504
  • [7] Efficacy assessment and pre-clinical toxicology of AAV2/8-hCARp.hCNGB3, a CNGB3 gene therapy vector
    Telfer, J.
    Georgiadis, A.
    Duran, Y.
    Ribeiro, J.
    Abelleira, L.
    Naylor, S.
    Smith, A. J.
    Bainbridge, J. W. B.
    Ali, R. R.
    HUMAN GENE THERAPY, 2017, 28 (12) : A76 - A77
  • [8] Treatment of Patients with Leber Congenital Amaurosis Type 2 with an AAV Vector Expressing RPE65
    Stout, Tim
    Weleber, Richard
    McBride, Maureen
    Wilson, David
    Peters, Dawn
    Humphries, Margaret
    Flotte, Terence
    Jensen, Lauren
    Lauer, Andreas
    Chulay, Jeffrey
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [9] Rescue of Degenerating Photoreceptors in the RCS Rat by an AAV2/4-RPE65-Mertk Vector
    Heiduschka, P.
    Ulien, S.
    Guenther, A.
    Ziemssen, F.
    Schultheiss, S.
    Schraermeyer, U.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] Clinical trial of gene therapy for inherited retinal dystrophy caused by RPE65 deficiency
    Bainbridge, James
    Robbie, Scott
    Smith, Alexander
    Barker, Susan
    Fitzke, Fred
    Moore, Anthony
    Yzer, Suzane
    van den Born, Ingeborgh
    Rubin, Gary
    Ali, Robin
    HUMAN GENE THERAPY, 2009, 20 (11) : 1368 - 1368
1234